A case of Rifampicin induced pseudomembraneous colitis

Authors

• Daad H. Akbar, Associate Professor/Consultant Physician, PO Box 127191, Jeddah 21352, Kingdom of Saudi Arabia. Tel. +966 (2) 6944856. Fax. +966 (2) 6944857. E-mail: daadakb{at}yahoo.com
• Halia Z. Al-Shehri, Department of Medicine, King Abdul-Aziz University Hospital, Jeddah, Kingdom of Saudi Arabia.
• Amani M. Al-Huzali, Department of Medicine, King Abdul-Aziz University Hospital, Jeddah, Kingdom of Saudi Arabia.
• Hind I. Falatah, Department of Medicine, King Abdul-Aziz University Hospital, Jeddah, Kingdom of Saudi Arabia.

Abstract

We report a case pf pseudomembranous colitis that developed in a patient with tuberculous abdominal lymphadenopathy during treatment with rifampicin. The patient had delayed presentation (3 months) after the start of rifampicin. She had one relapse after 2 months that was successfully treated, and she finished her antituberculosis therapy without any further relapses. Awareness of this serious complication of rifampicin therapy should be encountered.

Article Type

Case Report

First Page

1391

Last Page

1393

Recommended Citation

Akbar, Daad H.; Al-Shehri, Halia Z.; Al-Huzali, Amani M.; and Falatah, Hind I. (2003) "A case of Rifampicin induced pseudomembraneous colitis," Saudi Medical Journal: Vol. 24: Iss. 12, Article 22.
DOI: https://doi.org/10.15537/1658-3175.2259